AKT1 and hepatocellular carcinoma: As depicted in Table 3, ISL exhibits toxic effects on Hep3B hepatoma cells by inducing cell cycle arrest at the G1/S checkpoints, suppressing migration and metastasis and the PI3K/AKT signal pathway (IC50 = 42.84 ± 2.01 μM).